Tango Therapeutics Overview
Tango Therapeutics Target Price
Analysts' 12-month price predictions for TNGX.
Get informed when a big investor buys or sells
+ FollowShare Price
$29.46
Average Target Price
$39.93
35.5% upside
35.5% upside14 analysts in the last 4 months
High: $69 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-25 | Jefferies | $60 | 103.7% upside |  |
| 2026-06-09 | H.C. Wainwright | $66 | 124% upside | |
| 2026-06-09 | Canaccord Genuity | $42 | 42.6% upside | |
| 2026-06-08 | Leerink Partners | $69 | 134.2% upside | |
| 2026-06-08 | Mizuho SecuritiesJoseph Catanzaro | $36 | 22.2% upside | |
| 2026-06-08 | Wolfe Research | $35 | 18.8% upside | |
| 2026-05-15 | Mizuho SecuritiesJoseph Catanzaro | $30 | 1.8% upside | |
| 2026-05-14 | Piper Sandler | $24 |  18.5% downside | |
| 2026-05-14 | UBS | $55 | 86.7% upside | |
| 2026-05-14 | Wedbush | $33 | 12% upside | |
| 2026-05-14 | JefferiesMaury Raycroft | $27 | 8.4% downside | |
| 2026-04-27 | Stifel Nicolaus | $40 | 35.8% upside | |
| 2026-03-09 | Stifel NicolausLaura Prendergast | $24 | 18.5% downside | |
| 2026-03-05 | JefferiesMaury Raycroft | $18 | 38.9% downside | |
| 2026-02-23 | Mizuho Securities | $19 | 35.5% downside | |
| 2026-01-16 | Piper Sandler | $14 | 52.5% downside | |
| 2025-12-03 | Stifel Nicolaus | $15 | 49.1% downside | |
| 2025-10-24 | GuggenheimMichael Schmidt | $12 | 59.3% downside | |
| 2024-09-17 | Piper SandlerJoseph Catanzaro | $18 | 38.9% downside | |
| 2024-08-08 | WedbushRobert Driscoll | $13 | 55.9% downside | |
| 2024-05-28 | H.C. WainwrightRobert Burns | $13 | 55.9% downside | |